← FDA Drug Approvals (Drugs@FDA)

VIGPODER

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PYROS PHARMS · Approved 2022-06-24

Drug application

FDA Application #

ANDA214961

Application type

Abbreviated New Drug Application (Generic)

Brand name

VIGPODER

Generic name

Vigabatrin

Active ingredients

VIGABATRIN

Dosage form

FOR SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

PYROS PHARMS

First approval

2022-06-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown